Predictors of cardiovascular disease in asthma and chronic obstructive … – 7thSpace Interactive (press release)

Predictors of cardiovascular disease in asthma and chronic obstructive
7thSpace Interactive (press release)
Cardiovascular disease (CVD) is a common comorbidity in patients with chronic airway obstruction, and is associated with systemic inflammation and airway obstruction. The aim of this study was to evaluate the predictors of CVD in two different

View full post on asthma – Google News

Programs address cardiovascular disease, immunization, asthma and reducing … – The FINANCIAL

Programs address cardiovascular disease, immunization, asthma and reducing
The FINANCIAL
Each pilot program addresses a region-specific health issue such as heart disease and diabetes, childhood immunization, asthma and respiratory disease management, and patient compliance and retention. “GE recognizes there is a critical need in the U.S.

and more »

View full post on asthma – Google News

Budesonide/Formoterol for Asthma Shows Cardiovascular Safety – Family Practice News Digital Network

Budesonide/Formoterol for Asthma Shows Cardiovascular Safety
Family Practice News Digital Network
ORLANDO – Budesonide/formoterol pressurized metered-dose inhaler demonstrated similar cardiovascular safety to that of budesonide treatment alone in a study of 742 black adolescents and adults with moderate to severe asthma. There has been concern that

View full post on asthma – Google News

ASNC: Regadenoson safe in patients with asthma, COPD – Cardiovascular Business

ASNC: Regadenoson safe in patients with asthma, COPD
Cardiovascular Business
PHILADELPHIA—The use of the pharmacologic stressor regadenoson (Lexiscan, Astellas Pharma) in patients with asthma and chronic obstructive pulmonary
Safety and Tolerability of Regadenoson in Patients With Asthma or COPDPR Newswire (press release)

all 11 news articles »

View full post on asthma – Google News